N-Acetyl-beta-D-glucosaminidase in acute myocardial infarction.
- Author:
M Perwaiz IQBAL
1
;
Khawar A KAZMI
;
Hasan R JAFRI
;
Naseema MEHBOOBALI
Author Information
1. Department of Biological and Biomedical Sciences, The Aga Khan University, Stadium Road Karachi-74800, Pakistan. iqbal@aku.edu
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
acetylglucosaminidase;
biological markers;
inflammation;
lysosomes;
myocardial infarction
- MeSH:
Acetylglucosaminidase/blood/*metabolism;
Adult;
Aged;
Female;
Human;
Male;
Middle Aged;
Myocardial Infarction/*enzymology/metabolism/physiopathology
- From:Experimental & Molecular Medicine
2003;35(4):275-278
- CountryRepublic of Korea
- Language:English
-
Abstract:
The objective of the study was to investigate whether the lysosomal enzyme, N-Acetyl-beta-D-glucosaminidase (NAG) activity is increased in plasma of patients with acute myocardial infarction (AMI) and to determine if there is any association between plasma levels of NAG and severity of myocardial infarction (MI). NAG activity in plasma was monitored in 69 patients with AMI and 135 normal healthy subjects using a spectrofluorimetric method. A modified Aldrich ST elevation score was used to gauge the severity of MI in terms of size of the infarct. Plasma NAG levels in AMI patients and normal healthy subjects were found to be 10.92+/-7.5 U/l and 6.8+/-2.2 U/l, respectively. These two mean value when compared by Student's t-test were significantly different P = 0.0001. No statistically significant differences in NAG activity were observed in patients in terms of gender, age, location of infarct, time from onset of chest pain to blood sampling in the hospital and size of the infarct.
